Lupin Ltd. - Lupin Ltd reply to clarification sought by the exchange

February 29, 2016 - 04:28:00 PM

The Exchange had sought clarification from Lupin Ltd with respect to news article appearing in The Economic Times on February 25, 2016 titled "Lupin Plans to Step Up Japanese Play"

Lupin Ltd replied stating "We wish to state that Kyowa Pharmaceutical Industry Co., Ltd., Japan, ('Kyowa'), wholly-owned subsidiary of the Company has a Plant at Sanda, Japan.

In order to meet the rapidly growing demand of generics, the Kyowa Board has proposed the setting-up of a 2 Bn. Tablets capacity Plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion."

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS